Literature DB >> 1649573

Spontaneous quinolone resistance in Serratia marcescens due to a mutation in gyrA.

B L Masecar1, N J Robillard.   

Abstract

Spontaneous quinolone-resistant mutants of MP050, a quinolone-susceptible clinical strain of Serratia marcescens, were isolated on nutrient agar containing 0.5 microgram of ciprofloxacin per ml. One mutant, designated MP051, was selected for further study. Quinolone MICs for MP051 were 4- to 16-fold higher than those for MP050; nonquinolone MICs were unchanged. The DNA gyrase isolated from MP051 was 24-fold less sensitive to inhibition of supercoiling by ciprofloxacin than the DNA gyrase isolated from MP050 was. Inhibition studies on reconstituted combinations of heterologous gyrase subunits showed that the decreased inhibition was dependent on the A subunit of DNA gyrase from MP051. Further evidence that this decreased inhibition was due to a gyrA mutation was provided by analysis of Escherichia coli gyrA gene expression in S. marcescens heterodiploids containing pNJR3-2, a broad-host-range gyrA gene probe. Quinolone susceptibilities of MP051 heterodiploids containing the wild-type E. coli gyrA gene decreased to those of MP050, while quinolone susceptibilities of MP050 containing the same plasmid were unchanged. These results indicate that spontaneous quinolone resistance in MP051 was due to a mutation in gyrA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1649573      PMCID: PMC245126          DOI: 10.1128/AAC.35.5.898

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  37 in total

1.  gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli.

Authors:  S Nakamura; M Nakamura; T Kojima; H Yoshida
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

2.  Emergence of resistance to beta-lactams, aminoglycosides, and quinolones during combination therapy for infection due to Serratia marcescens.

Authors:  C C Sanders; C Watanakunakorn
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

3.  Elimination of plasmids by new 4-quinolones.

Authors:  J Weisser; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

Review 4.  Some properties of Serratia marcescens, Salmonella paratyphi A, and Enterobacter cloacae with non-enzyme-dependent multiple resistance to beta-lactam antibiotics, aminoglycosides, and quinolones.

Authors:  P Dang; L Gutmann; C Quentin; R Williamson; E Collatz
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

5.  Proportion of DNA gyrase mutants among quinolone-resistant strains of Pseudomonas aeruginosa.

Authors:  H Yoshida; M Nakamura; M Bogaki; S Nakamura
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

6.  Quinolone resistance in clinical isolates of Serratia marcescens.

Authors:  K Fujimaki; T Fujii; H Aoyama; K Sato; Y Inoue; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

7.  Resistance emerging after pefloxacin therapy of experimental Enterobacter cloacae peritonitis.

Authors:  C Lucain; P Regamey; F Bellido; J C Pechére
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

8.  Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12.

Authors:  K Hirai; H Aoyama; S Suzue; T Irikura; S Iyobe; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

9.  Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies.

Authors:  M W Hane; T H Wood
Journal:  J Bacteriol       Date:  1969-07       Impact factor: 3.490

10.  Incomplete cross-resistance of nalidixic and pipemidic acid-resistant variants of Serratia marcescens against ciprofloxacin, enoxacin, and norfloxacin.

Authors:  W H Traub
Journal:  Chemotherapy       Date:  1985       Impact factor: 2.544

View more
  5 in total

1.  Cloning and nucleotide sequence of the DNA gyrase gyrA gene from Serratia marcescens and characterization of mutations in gyrA of quinolone-resistant clinical isolates.

Authors:  J H Kim; E H Cho; K S Kim; H Y Kim; Y M Kim
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

Review 2.  Serratia infections: from military experiments to current practice.

Authors:  Steven D Mahlen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

3.  Acute bacterial diarrhoea in the emergency room: therapeutic implications of stool culture results.

Authors:  N Kaminski; V Bogomolski; R Stalnikowicz
Journal:  J Accid Emerg Med       Date:  1994-09

Review 4.  Mechanisms of resistance to quinolones.

Authors:  E Cambau; L Gutmann
Journal:  Drugs       Date:  1993       Impact factor: 9.546

5.  In vitro studies with five quinolones: evidence for changes in relative potency as quinolone resistance rises.

Authors:  K S Thomson; C C Sanders; M E Hayden
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.